From: RPL35A is a key promotor involved in the development and progression of gastric cancer
Features | No. of patients | RPL35A expression | P value | |
---|---|---|---|---|
Low | High | |||
All patients | 110 | 65 | 45 | |
Age (years) | 0.070 | |||
< 64 | 53 | 36 | 17 | |
≥ 64 | 57 | 29 | 28 | |
Gender | 0.869 | |||
Male | 84 | 50 | 34 | |
Female | 26 | 15 | 11 | |
T Infiltrate | 0.042 | |||
T1 | 5 | 4 | 1 | |
T2 | 17 | 11 | 6 | |
T3 | 65 | 41 | 24 | |
T4 | 23 | 9 | 14 | |
Lymphatic metastasis (N) | 0.754 | |||
N0 | 20 | 13 | 7 | |
N1 | 18 | 12 | 6 | |
N2 | 26 | 12 | 14 | |
N3 | 46 | 28 | 18 | |
Stage | 0.631 | |||
I | 9 | 5 | 4 | |
II | 32 | 21 | 11 | |
III | 68 | 38 | 30 | |
IV | 1 | 1 | 0 | |
Tumor size | 0.591 | |||
< 5 cm | 46 | 26 | 20 | |
≥ 5 cm | 55 | 34 | 21 | |
Vessel carcinoma embolus | 0.539 | |||
0 | 26 | 14 | 12 | |
1 | 54 | 33 | 21 | |
Nerve tumor infiltrates | 0.425 | |||
0 | 36 | 22 | 14 | |
1 | 20 | 10 | 10 | |
Expession of Ki67 | 0.404 | |||
< 60% | 47 | 25 | 22 | |
≥ 60% | 52 | 32 | 20 | |
Expession of CD34 | 0.346 | |||
No | 15 | 6 | 9 | |
Yes | 29 | 16 | 13 | |
Expession of EGFR | 0.531 | |||
No | 85 | 47 | 38 | |
Yes | 14 | 9 | 5 | |
Expession of VEGF | 0.343 | |||
No | 34 | 17 | 17 | |
Yes | 65 | 39 | 26 | |
Expession of CDX2 | 0.892 | |||
No | 18 | 10 | 8 | |
Yes | 82 | 47 | 35 | |
Expession of Her2 | 0.948 | |||
No | 72 | 41 | 31 | |
Yes | 26 | 15 | 11 |